Bupa Arabia for Cooperative Insurance Company (8210) Q2 2024 earnings summary

Executive summary

• Achieved robust profitability growth and significant value creation for shareholders, with over 25 years of experience and a leading market position.

• Implemented the 3B strategy to transform into a healthcare company by 2030, focusing on core business, medical inflation control, and vertical integration.

• Interim results for the three- and six-month periods ended 30 June 2024 show strong growth in revenue and profitability year-over-year.

• The company operates exclusively in medical insurance, with all activities in Saudi Arabia.

• The interim financials were reviewed by independent auditors, with no material misstatements identified.

Financial highlights

• H1-24 EBT increased by approximately 33% year-over-year, driven by strong business performance and higher investment income.

• Insurance revenue rose 17% year-over-year to SAR 8.9B in H1-24.

• Net income after zakat and income tax for six months was SR 764 million, up from SR 560 million year-over-year.

• Basic and diluted EPS for six months increased to SR 5.10 from SR 3.75 year-over-year.

• Investment income grew by 52% in H1-24, supported by favorable interest rates and a 13% larger portfolio.

Outlook and guidance

• Strategic focus on expanding healthcare offerings and leveraging data analytics to sustain market leadership.

• Continued emphasis on controlling medical inflation and exploring new growth opportunities beyond traditional insurance.

• Management notes that due to seasonality, operating profits are expected to fluctuate between periods.

• Interim results may not be indicative of full-year performance.